We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new study by health officials in England shows for the first time that two doses of COVID-19 vaccines are “highly effective” against the B1.617.2 variant first identified in India.